Clinical Trials | April 15, 2025
Dr. Lal PathLabs becomes South Asia's first to launch advanced test for amyloidosis
More than 40 types of Amyloid proteins are discovered till date
More than 40 types of Amyloid proteins are discovered till date
Protein research is key to advancing our understanding of human biology and delivering on the promise of precision medicine
The new 10-year contract will focus on strengthening the partnership for continued transformative innovation for patients
The companies will spread the adoption of the latest HOS and Mass Spec technologies to help scientists improve the safety, stability, and effectiveness of biotherapeutics
The award recognizes and supports promising female scientists working in mass spectrometry
Thermo Fisher is working closely with large pharmaceutical businesses to develop companion diagnostics in multiple areas such as heart disease, neurosciences and infectious diseases.
New mass spectrometry instrument and consumables launch during IMSC 2022
NADMED technology is based on proprietary extraction and the individual measurement of NAD metabolites
_256_384.png)
Thermo Scientific Direct Mass Technology mode augments Thermo Scientific Q Exactive UHMR Hybrid Quadrupole-Orbitrap mass spectrometers with charge detection capabilities
Co-marketing agreement between Thermo Fisher Scientific and TransMIT allows for high spatial and high mass resolution MSI platform to study complex biological tissues
Subscribe To Our Newsletter & Stay Updated
